Replies to post #133931 on Anavex Life Sciences Corp (AVXL)

[anders2211]

Well I dont think that is Misslings fault. FDA is as we know not the world most fast mean and lean organization. So it could take a few months easy before the new protocol is in place. As soon as it its out there it would expedite all planned trial especially Alzheimer trial. As soon as the FDA has published its new protocol for CNS we will, probably, see a jump in the SP for all CNS biotechs and BOP... IMO